autosomal dominant hypophosphatemic rickets or oncogenic osteomalacia. As there is little evidence that moderate hypophosphatemia (1.0-2.5 mg/dl [0.3-0.8 mmol/l]) has significant clinical ...
Children with this condition typically develop autosomal-recessive hypophosphatemic rickets type 2 (ARHR2), while adolescents and adults may develop osteomalacia, or softened bones. ARHR2 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback